Short interest in CytomX Therapeutics, Inc. (NASDAQ: CTMX) decreased by 21.7% in November.
CytomX Therapeutics, Inc. experienced a notable decrease in short interest during November, with a total of 4,440,000 short interests recorded as of November 15th.
